“Mavacamten and the Reframing of Obstructive Hypertrophic Cardiomyopathy as a Medically Treatable Disease”, JHCS, vol. 3, no. 1, pp. 16–21, Oct. 2022, doi: 10.5281/zenodo.22344598.